Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jul;11(7):519-24.

Use of duplex mutation primers for real-time PCR quantification of hepatitis C virus RNA in serum

Affiliations

Use of duplex mutation primers for real-time PCR quantification of hepatitis C virus RNA in serum

Qian-Feng Xia et al. Hepat Mon. 2011 Jul.

Abstract

Background: The duplex mutation primers offer many advantages over other multi-labeled probes for real-time detection of amplification products.

Objectives: To develop and validate a novel real-time PCR for quantification of HCV RNA based on the duplex mutation primers technology.

Materials and methods: The duplex mutation primers were selected in the highly conservative 5' non-coding region (5'NCR) of the HCV RNA. The assay was validated with the Viral Quality Control panel, which also includes Chinese HCV RNA standards.

Results: The detection limit was 57 IU/mL, and a good linear correlation in the range of 102-108 IU/mL was revealed (r(2) = 0.999) with the novel method. This assay has a dynamic range of at least 8 log10 without the need for specimen dilution, good clinical intra- and inter-run precision, and excellent correlation with a commercially available assay(r(2) = 0.95).

Conclusions: The high sensitivity, wide linear range, and good reproducibility, combined with low cost, make this novel quantitative HCV real-time PCR assay particularly well suited for application to clinical and epidemiological studies.

Keywords: Duplex mutation primers; HCV; Hepatitis; PCR; Quantification.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Figures

Figure 1
Figure 1
Fluorescent curves of the standard dilution series.
Figure 2
Figure 2
Graph shin correlation of the HCV real-time PCR ass av results with the new method results for 92 HCV-positive clinical spcimens (numerical values e not listed). Thre was excellent correlation (r 0. 95) between the two assays for all samples.

Similar articles

References

    1. Forman MS, Valsamakis A. Verification of an assay for quantification of hepatitis C virus RNA by use of an analyte-specific reagent and two different extraction methods. J Clin Microbiol. 2004;42(8):3581–8. - PMC - PubMed
    1. Jongerius JM, Sjerps M, Cuijpers HT, van Drimmelen HA, van der Poel CL, Reesink HW, Molijn MH, Peeters GA, Peeters TP, Lelie PN. Validation of the NucliSens Extractor combined with the AmpliScreen HIV version 1.5 and HCV version 2.0 test for application in NAT minipool screening. Transfusion. 2002;42(6):792–7. - PubMed
    1. Konnick EQ, Williams SM, Ashwood ER, Hillyard DR. Evaluation of the COBAS Hepatitis C Virus (HCV) TaqMan analyte-specific reagent assay and comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 assays. J Clin Microbiol. 2005;43(5):2133–40. - PMC - PubMed
    1. Wittwer CT, Herrmann MG, Moss AA, Rasmussen RP. Continuous fluorescence monitoring of rapid cycle DNA amplification. Biotechniques. 1997;22(1):130–1, 4-8. - PubMed
    1. Holland PM, Abramson RD, Watson R, Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci U S A. 1991;88(16):7276–80. - PMC - PubMed

LinkOut - more resources